25e-nboh 25e-nboh 25e-nboh (2c-e-nboh, nboh-2c-e) is a derivative of the phenethylamine derived hallucinogen 2c-e. it was first developed by martin hansen at the university of copenhagen in 2010 as a brain imaging agent, but has subsequently been sold as a designer drug, first being identified in brazil in 2018 on seized blotter paper, as well as in slovenia. it acts as a potent serotonin receptor agonist with similar affinity to better-known compounds such as 25i-nbome at 5-ht2a and 5-ht2c receptors. 25e-nbohlegal statuslegal status de: npsg (industrial and scientific use only) uk: class a identifiers iupac name 2-(methyl)phenol cas number1391489-79-4hydrochloride: 1539266-40-4pubchem cid135391539uniieb0ku6r3bechemical and physical dataformulac19h25no3molar mass315.413 g·mol−13d model (jsmol)interactive image smiles ccc1=cc(=c(c=c1oc)ccncc2=cc=cc=c2o)oc inchi inchi=1s/c19h25no3/c1-4-14-11-19(23-3)15(12-18(14)22-2)9-10-20-13-16-7-5-6-8-17(16)21/h5-8,11-12,20-21h,4,9-10,13h2,1-3h3key:sybintrpezwflz-uhfffaoysa-n legal status united kingdom this substance is a class a drug in the united kingdom as a result of the n-benzylphenethylamine catch-all clause in the misuse of drugs act 1971.